CTI Analyzes TB Natural History Database
The analysis compared various manifestations between genotypes and to determine if correlations exist between TSC symptoms and the TSC gene mutation.
CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization announced it recently collaborated with the Tuberous Sclerosis Alliance to analyze a Natural History Database of currently more than 1,700 people with tuberous sclerosis complex (TSC).
The analysis compared various manifestations between genotypes and to determine if correlations exist between TSC symptoms and the TSC gene mutation. CTI believes that patient disease groups are increasingly more important in drug development and research in rare diseases, and is working to advance these kind of collaborations and research efforts.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
